Page last updated: 2024-10-29

ketoprofen and Arterial Obstructive Diseases

ketoprofen has been researched along with Arterial Obstructive Diseases in 2 studies

Ketoprofen: An IBUPROFEN-type anti-inflammatory analgesic and antipyretic. It is used in the treatment of rheumatoid arthritis and osteoarthritis.
ketoprofen : An oxo monocarboxylic acid that consists of propionic acid substituted by a 3-benzoylphenyl group at position 2.

Research Excerpts

ExcerptRelevanceReference
" The purpose of this study was to evaluate the effect of focal cerebral ischaemia in the rat through the dosage of the glutamate and morphological findings, and to evaluate a possible protective effect of the ketoprofen to ischemic neurons."1.31[Focal cerebral ischaemia induced by middle cerebral artery occlusion and the neuroprotective effect of ketoprofen in rats]. ( Colli, BO; Coutinho Netto, J; Dias, LA; Lachat, JJ, 2000)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Persico, G1
Amato, B1
Aprea, G1
Cerfolio, P1
Markabaoui, AK1
Dias, LA1
Colli, BO1
Coutinho Netto, J1
Lachat, JJ1

Trials

1 trial available for ketoprofen and Arterial Obstructive Diseases

ArticleYear
The early effects of intravenous L-propionyl carnitine on ulcerative trophic lesions of the lower limbs in arteriopathic patients: a controlled randomized study.
    Drugs under experimental and clinical research, 1995, Volume: 21, Issue:5

    Topics: Aged; Aged, 80 and over; Amputation, Surgical; Anti-Inflammatory Agents, Non-Steroidal; Arterial Occ

1995

Other Studies

1 other study available for ketoprofen and Arterial Obstructive Diseases

ArticleYear
[Focal cerebral ischaemia induced by middle cerebral artery occlusion and the neuroprotective effect of ketoprofen in rats].
    Arquivos de neuro-psiquiatria, 2000, Volume: 58, Issue:4

    Topics: Animals; Arterial Occlusive Diseases; Brain Ischemia; Case-Control Studies; Cyclooxygenase Inhibitor

2000